Jetbio – The future of 3D bioprinting systems
Reactive jet impingement (ReJI) bioprinting technology is a fast, flexible system for printing biomimetic cell filled gels for use in developing in vitro disease models for drug testing, or to support regenerative medicine.
Jetbio – The future of 3D bioprinting systems
Reactive jet impingement (ReJI) bioprinting technology is a fast, flexible system for printing biomimetic cell filled gels for use in developing in vitro disease models for drug testing, or to support regenerative medicine.
Innovative solution
Jetbio 3D bioprinting integrated systems with microvalve and inkjet heads, user-friendly software and bio-ink materials that together deliver printed models very rapidly , accurately and almost on any substrate. Patents filed and granted in Europe and the USA.

World-class team
A blend of skills in hardware and software product development, manufacturing engineering and business development, ready to collaborate and support its customers to ensure successful delivery of bioprinting applications.

Drug discovery focus
It can take 10 years to develop a drug to market and costing over £800 million with over 90% failure rate!
Jetbio systems can accelerate and improve drug discovery and ultimately reduce cost of pre-clinical drug development. Jetbio 3D tissue models for drug discovery can bring the right drug compounds to clinical trials much faster.

Excellent research
Founded on years of funded research at Newcastle University with practical bioprinting outcomes.
Greater accuracy, faster, almost any substrate
Very high cell density gels for physiological accuracy. Substrates including fibre substrates to create cell-gel-fibre composites for additional functionality.
Jetbio can print 3D cardiac cell cultures where the cells “beat” in time with each other.
Latest News
Jetbio is collaborating with Newcastle, Bristol and Cambridge Universities to develop bioprinters for a range of in vitro models demonstrated in three workshops which will promote the use of bioprinting for in vitro models.